Despite progress in pediatric attention-deficit/hyperactivity disorder (ADHD) research over the past decade, no one genetic variant or currently available pharmacogenomics test has predicted with precision which ADHD medications will be most effective for individual patients, according to a review article published in CNS Drugs.